Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study

Autores da FMUP
Participantes de fora da FMUP
- Valiulis, Arunas
- Melen, Erik
- Koppelman, Gerard H.
- Papadopoulos, Nikolaos G.
- Makela, Mika
- Haahtela, Tari
- Bonini, Matteo
- Braido, Fulvio
- Brussino, Luisa
- Cruz, Alvaro A.
- Fiocchi, Alessandro
- Giovannini, Mattia
- Gemicioglu, Bilun
- Kulus, Marek
- Kuna, Piotr
- Kupczyk, Maciej
- Kvedariene, Violeta
- Larenas-Linnemann, Desiree E.
- Louis, Renaud
- Morais-Almeida, Mario
- Niedoszytko, Marek
- Ollert, Markus
- Pfaar, Oliver
- Regateiro, Frederico S.
- Roberts, Graham
- Samolinski, Boleslaw
- Savoure, Marine
- Taborda-Barata, Luis
- Toppila-Salmi, Sanna
- Ventura, Maria Teresa
- Vazquez-Ortiz, Marta
- Yorgancioglu, Arzu
- Zuberbier, Torsten
- Anto, Josep M.
- Bousquet, Jean
- Nhan, Pham-Thi
- MASK-Air Think Tank
Unidades de investigação
Abstract
Background: In allergic rhinitis and asthma, adolescents and young adult patients are likely to differ from older patients. We compared adolescents, young adults and adults on symptoms, control levels, and medication adherence. Methods: In a cross-sectional study (2015-2022), we assessed European users of the MASK-air mHealth app of three age groups: adolescents (13-18 years), young adults (18-26 years), and adults (>26 years). We compared them on their reported rhinitis and asthma symptoms, use and adherence to rhinitis and asthma treatment and app adherence. Allergy symptoms and control were assessed by means of visual analogue scales (VASs) on rhinitis or asthma, the combined symptom-medication score (CSMS), and the electronic daily control score for asthma (e-DASTHMA). We built multivariable regression models to compare symptoms or medication accounting for potential differences in demographic characteristics and baseline severity. Results: We assessed 965 adolescent users (15,252 days), 4595 young adults (58,161 days), and 15,154 adult users (258,796 days). Users of all three age groups displayed similar app adherence. In multivariable models, age groups were not found to significantly differ in their adherence to rhinitis or asthma medication. These models also found that adolescents reported lower VAS on global allergy, ocular, and asthma symptoms (as well as lower CSMS) than young adults and adults. Conclusions: Adolescents reported a better rhinitis and asthma control than young adults and adults, even though similar medication adherence levels were observed across age groups. These results pave the way for future studies on understanding how adolescents control their allergic diseases.
© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Dados da publicação
- ISSN/ISSNe:
- 1399-3038, 0905-6157
- Tipo:
- Article
- Páginas:
- -
- DOI:
- 10.1111/pai.14080
- Link para outro recurso:
- www.scopus.com
Pediatric Allergy and Immunology Blackwell Munksgaard
Citações Recebidas na Web of Science: 2
Citações Recebidas na Scopus: 6
Documentos
- Não há documentos
Filiações
Keywords
- adherence; adolescents; allergic rhinitis; asthma; digital health; mHealth; real-world data
Proyectos asociados
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021
Effect of a Mobile App on Improving Asthma Control in Adolescents and Adults With Persistent Asthma: A Pilot Randomized Multicentre, Superiority Clinical Trial (mINSPIRERS) - NCT05129527
Investigador Principal: João de Almeida Lopes da Fonseca
Ensaio Clínico Académico (mINSPIRERS) . 2021
Utilização em estudos observacionais do Registo de Asma Grave Portugal.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Observacional Académico (RAG) . 2020
Clinical Research Collaboration Severe Heterogenous Asthma Research collaboration, Patient-centered (CRC SHARP).
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (SHARP) . European Respiratory Society . 2021
Multidimensional phenotyping of severe asthma patients and its impact on disease control and therapeutic response - analysis from the Portuguese Severe Asthma Registry.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (RAG-SPP-GSK) . SPPneumologia . 2022
BREATHE - An oBservational, pRimary data study to characterize severe AsThma pHenotypes and assEss disease burden across the EUCAN region.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (RAG-AZ-BREATHE) . AstraZeneca . 2022
Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers
Investigador Principal: Bernardo Manuel De Sousa Pinto
Estudo Clínico Académico (SARS-CoV-2) . 2021
Efficiency in Spine Care ? Assessing outcomes and costs to inform healthcare improvement
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2022
Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Citar a publicação
Sousa B,Valiulis A,Melen E,Koppelman GH,Papadopoulos NG,Makela M,Haahtela T,Bonini M,Braido F,Brussino L,Cruz AA,Fiocchi A,Giovannini M,Gemicioglu B,Kulus M,Kuna P,Kupczyk M,Kvedariene V,Larenas DE,Louis R,Morais M,Niedoszytko M,Ollert M,Pfaar O,Regateiro FS,Roberts G,Samolinski B,Savoure M,Taborda L,Toppila S,Ventura MT,Vazquez M,Vieira RJ,Fonseca JA,Yorgancioglu A,Zuberbier T,Anto JM,Bousquet J,Nhan P,MASK T. Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study. Pediatr. Allergy Immunol. 2024. 35. (2):e14080. IF:4,400. (1).